Long-term hormone replacement therapy does not cause increased platelet activation

American Heart Journal

Volumn 150, Issue 3, 2005, Pages 434-438

  Williams, Marlene S ^a,b   Vaidya, Dhananjay ^a   Kickler, Thomas ^a   Ouyang, Pamela ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; CONJUGATED ESTROGEN; ESTRADIOL; MONOCLONAL ANTIBODY; PAC 1 PROTEIN; PAC1 PROTEIN; PADGEM PROTEIN; PLACEBO; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DRUG SCREENING; ESTROGEN THERAPY; FEMALE; FLOW CYTOMETRY; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MEASUREMENT; PATIENT; PLASMA; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARD; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VEIN GRAFT DISEASE;

AGED; AGED, 80 AND OVER; CORONARY ARTERIOSCLEROSIS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PLATELET ACTIVATION; TIME FACTORS;

EID: 24944490908     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.10.028     Document Type: Article

References (25)

1. D. Grady, S.M. Rubin, and D.B. Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
2. J.E. Manson Postmenopausal hormone therapy and atherosclerotic disease Am Heart J 128 1994 1337 1343
3. F. Grodstein, M.J. Stampfer, and J.E. Manson Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
4. M.J. Stampfer, G.A. Colditz, and W.C. Willett Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study N Engl J Med 325 1991 756 762
5. B.M. Psaty, S.R. Heckbert, and D. Atkins The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women Arch Intern Med 154 1994 1333 1339
6. B.E. Henderson, A. Paganini-Hill, and R.K. Ross Decreased mortality in users of estrogen replacement therapy Arch Intern Med 151 1991 75 78
7. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
8. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
9. E. Hoibraaten, E. Qvigstad, and H. Arnesen Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET) Thromb Haemost 84 2000 961 967
10. E. Hoibraaten, E. Qvigstad, and T.O. Andersen The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism-results from a randomized, double-blind, clinical trial Thromb Haemost 85 2001 775 781
11. M. Notelovitz, C. Kitchens, and M. Ware Combination estrogen and progestogen replacement therapy does not adversely affect coagulation Obstet Gynecol 62 1983 596 600
12. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
13. K.K. Wu, and P. Thiagarajan Role of endothelium in thrombosis and hemostasis Annu Rev Med 47 1996 315 331
14. A. Thijs, W.M. van Baal, and M.J. van der Mooren Effects of hormone replacement therapy on blood platelets Eur J Clin Invest 32 2002 613 618
15. H.J. Teede, B.P. McGrath, and A. Turner Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women Clin Sci (Lond) 100 2001 207 213
16. M.S. Williams, B.S. Coller, and H.J. Vaananen Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro) Circulation 98 1998 742 748
17. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
18. J. Bar, J. Lahav, and M. Hod Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17β-estradiol and medroxyprogesterone acetate in postmenopausal women Thromb Haemost 84 2000 695 700
19. M.E. Miller, G.M. Dores, and S.L. Thorpe Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions Thromb Res 74 1994 577 594
20. K.D. Boudoulas, G.E. Cooke, and C.M. Roos The PLA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation Arch Pathol Lab Med 125 2001 112 115
21. P.B. Kaplan, F. Gucer, and N.C. Sayin Effects of oral continuous and transdermal cyclic 17-β estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women J Reprod Med 47 2002 651 655
22. L.R. Ranganath, J. Christofides, and M.J. Semple Increased mean platelet volume after oestrogen replacement therapy Ann Clin Biochem 33 1996 555 560
23. B. Aune, P. Oian, and I. Omsjo Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood-a beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 173 1995 1816 1820
24. D. Woulfe, J. Yang, and L. Brass ADP and platelets: the end of the beginning J Clin Invest 107 2001 1503 1505
25. F. Grodstein, J.E. Manson, and M.J. Stampfer Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study. A prospective, observational study Ann Intern Med 135 2001 1 8